Skip to main content
University of Michigan Innovation Partnerships
University of Michigan Innovation Partnerships

Portfolio

PP2A Therapeutics

Use of High Resolution Structure of the Tumor Suppressive PP2A-B56ɑ Holoenzyme for Drug Discovery
(2019)

Soundbites Public Benefit Corporation

Micronutrient formula for hearing preservation and tinnitus symptom relief
(2019)

Sublime Pharma

Sublime, LLC is commercializing a vapor crystallization and printing technology that increases and controls dissolution/solubility and permits the combination of multiple types small molecules and compounds on any substrate, such as timed release patches. 
(2019)

Voxel51

Voxel51's state of the art video understanding platform uses cutting edge AI methods to transform video into value
(2019)

Zenithnano Technology

Flexible, transparent metal conductors for touch screen, LED, smart window, and photovoltaics manufacturers needing low resistance products over large areas
(2019)

Akadeum

Platform for isolating cells and other biological targets
(2018)

Censys

Platform that helps information security practitioners discover, monitor, and analyze devices that are accessible from the Internet.
(2018)

Fifth Eye

Improving quality of patient care with real-time early warning systems.
(2018)

Hantong Technology

Engineering structures subject to time-varying loads are prone to fatigue damage and failure.
(2018)

Kinetica

Mobile phone-based automated ergonomic risk assessment software
(2018)

May Mobility

Operating fleets of driverless cars in structured environments like central business districts, corporate campuses and dense residential developments.
(2018)

MPhasics

Nanoparticle fabrication
(2018)

NeuroLight Technologies

Optogenetic probes
(2018)

New Vital Signs

Wearable device to monitor and assess a patient's volume status and fluid responsiveness in critical and emergency care
(2018)

NS Nanotech

Energy efficient micro displays and UV light sources.
(2018)

Omniscent

Handheld MEMS-based VOC sensor system capable of detecting 20 VOC gases simultaneously
(2018)

Oncopia Therapeutics

BET and MDM2 degrader technologies
(2018)

Optofluidic Bioassay

Improving the conventional ELISA test workflow with disposable microfluidic 96-well plates that significantly decrease total assay time and significantly reduce both sample size and reagent consumption.
(2018)
1 5 6 7 8 9 10 11 20